Clinical trial
Vestipitant and Vofopitant 2 Day PSG Study for Insomnia
NCT00606697 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vestipitant and Vofopitant 2 Day PSG Study for Insomnia
- Lead sponsor
- GlaxoSmithKline
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 19, 2007
- Completion date
- May 7, 2008
- Enrollment
- 51 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.